A New Insertion Technique for Laryngeal Mask Airway

Status Completed

Clinical Trial Summary

A laryngeal mask airway ("LMA") is an airway device that is commonly used and placed under general anesthesia to facilitate ventilation of the patient's lungs while anesthetized. It is similar to an "endotracheal tube" (a breathing tube) but is less invasive. It is also placed as a backup when the Anesthesiologist is unable to pass a breathing tube and the patient is not adequately ventilating. Unfortunately, an LMA may lead to complications similar to those of breathing tube placement, such as sore throat and hoarse voice. Previous studies have examined several variables that may affect how often complications occur; these variables include giving anti-inflammatory medications and inflating the LMA to different pressures (the "working" end of the LMA, which rests in the patient's throat, has a cuff that is inflated to provide a seal). We are studying the effect of the PLACEMENT TECHNIQUE on postoperative sore throat, hoarse voice, and difficulty swallowing. We will be using 3 placement techniques - the traditional placement technique, a slightly different traditional placement technique, and a new technique, abbreviated the "ELLIA" method. The hypothesis of this study is that a new LMA insertion technique will have no difference in postoperative pharyngolaryngeal morbidity including sore throat, dysphagia and dysphonia.

Clinical Trial Description

The LMA will be inserted based on one of three methods randomly assigned to each patient. The ELLIA technique involves gently lifting the patient's laryngeal structures (throat) while placing the LMA to oppose the force of gravity. Whereas the traditional method of placement involves guiding the LMA through the pharynx with a finger inserted into the pharynx, the ELLIA method avoids this step. General anesthesia will be maintained at the discretion of the Anesthesiologist throughout the surgical procedure. At the end of the case, as would normally occur, the LMA will be removed from the patient's airway and the patient will be taken to the PACU, where he or she will be cared for as usual. At one and two hours postoperatively, blinded research assistants will assess the patient for sore throat, hoarse voice, and difficulty swallowing. Finally, at 24 hours the patient will receive a telephone call from a blinded research assistant assessing for the same outcomes. These data will be collected and presented. ;

Study Design

Related Conditions & MeSH terms

Airway Morbidity

Clinical Trial Details

NCT number	NCT01749033
Study type	Interventional
Source	Northwestern University
Contact
Status	Completed
Phase	N/A
Start date	November 2011
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04109898` - Comparison of Ease of I-gel Insertion With Two Different Techniques in Adults	N/A
Recruiting	`NCT05030337` - Optimising Ventilation in Preterms With Closed-loop Oxygen Control	N/A
Completed	`NCT02820792` - Non-Crossover Study of the LMA Protector Versus Ambu AuraGain	N/A
Not yet recruiting	`NCT02458794` - Crossover Study of the LMA SupremeTM vs Ambu-Aura GainTM	N/A
Completed	`NCT02572232` - Supraglottic Airway Devices in Pediatric Difficult Airway Situations	N/A
Completed	`NCT04158323` - What is the Gold Standard of Airway Management in the Anticipated Difficult Airway
Completed	`NCT04158271` - Evaluation of Techniques for Tracheal Tube Exchange in Standard and Critical Care Patients	N/A
Active, not recruiting	`NCT02627755` - GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways.	N/A
Completed	`NCT02923427` - I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery	N/A
Completed	`NCT02300337` - Comparison of Reduced Cuff-pressure of the Laryngeal Tube Under General Anesthesia	N/A
Completed	`NCT02611986` - Evaluation of Video Laryngoscopy (Video Macintosh-blade) and Direct Laryngoscopy (EMMA-Study)	N/A
Enrolling by invitation	`NCT03760692` - I-gel vs Ambu AuraGain in Laparoscopic Gynecological Surgery	N/A
Completed	`NCT01367678` - Mucosal Pressure of the Laryngeal Mask Airway Supreme Versus the i-Gel in Paralyzed Anesthetized Female Patients	N/A
Recruiting	`NCT03251053` - Adverse Airway Effects From Tobacco and E-Cigarettes	N/A
Recruiting	`NCT02777840` - High Flow Oxygen With THRIVE Gives Better Oxygenation in Rapid Sequence Induction Patients	N/A
Completed	`NCT02048657` - The Effectiveness of Foley Airway Stylet Tool on Proseal LMA Insertion	N/A
Completed	`NCT01371773` - Repositioning Method for Left-sided Double Lumen Tubes	N/A
Terminated	`NCT02495259` - Comparison of Double Lumen Tube Placement Techniques	N/A
Recruiting	`NCT02104453` - Comparative Evaluation of Three Airway Maneuvers in the Unconscious Apneic Person	N/A
Completed	`NCT02943980` - Influenced the Type of Laryngoscopy the Intraoperative Nerve Monitoring During Thyroid Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.